TGFB2 and prostate carcinoma: In another study of prostate cancer metastasis to the bone, Yumoto et al. identified osteoblast-derived ligand growth arrest specific 6 (GAS6) and the tumoral tyrosine kinase receptor Axl as required for the TGF-β2-induced response towards prostate cancer cell dormancy (41).